Council for Tobacco Research
[Expresses Frustration with Ctr]
Abstract
MAR
Fields
- Master ID
- Ctrmn00042811-3384
Related Documents:- CTRMN042811-3094 Deposition of James F. Glenn [Deposition of Glenn in the Matter of the State of Minnesota]
- CTRMN043095-3096 A Frank Statement to Cigarette Smokers [Response to Reports About Link Between Smoking and Lung Cancer]
- CTRMN043097-3103 Agenda Tobacco Industry Research Committee [Includes Information on Advertising and the Link Between Cancer and Smoking]
- CTRMN043104-3112 Forwarding Memorandum [Discusses Challenges Faced by the Tobacco Industry]
- CTRMN043113-3118 Background Material on the Cigarette Industry Client [St]
- CTRMN043119-3150 ""Best" Program for C.T.R." [Discusses How the Ctr Serves the Industry]
- CTRMN043151-3153 Statement by Timothy V. Hartrett, Chairman Tobacco Industry Research Committee [Information on Money Given by the Tobacco Industry Research Committee for Specific Scientific Research Projects Into Public Health Problems]
- CTRMN043154-3156 TIRC Program [Information on TIRC]
- CTRMN043157-3157 Hartrett Says Statistics Do Not Establish Causes [Discusses Cause-and-Effect Relationships]
- CTRMN043158-3167 Report on Visit to U.S.A. And Canada 17th April - 12th May 1958 ["Information About Lung Cancer and the Issue of "Causation""]
- CTRMN043168-3190 Survey of Cancer Research with Emphasis on Possible Carcinogens From Tobacco [Increased Incidence of Cancer of the Lung Is Due to Increased Contact with Carcinogenic Stimuli]
- CTRMN043191-3193 Scientist Comments on Benzpirene Report [Discounts the Role of Benzpyrene]
- CTRMN043194-3197 Cancer Scientist's Comments on Smoking-Lung Cancer Review [Discusses Evidence Which Conflicts with the Tobacco-Smoking Theories of Lung Cancer]
- CTRMN043198-3202 the Optimum Composition of Tobacco and Its Smoke [Discussion of Smoke Composition in Relation to Health and Smoking Enjoyment]
- CTRMN043203-3205 Gaps Still Exist in Knowledge of Lung Cancer and Heart Disease, Says Little [States That Many Clinical and Experimental Factors Still Need to Be Identified in Consideration of the Origin of Lung Cancer]
- CTRMN043206-3212 the Smoking and Health Problem--A Critical and Objective Appraisal [Discusses the Cigarette Smoke-Health Problem and the Potential Involvement of the Company's Research Department]
- CTRMN043213-3217 for Release at 6:30 P.M. Monday, February 3, 1969 [Discusses the Lack of A Demonstrated Causal Relationship Between Smoking and Disease]
- CTRMN043218-3223 Visit to Battelle Pacific Northwest Laboratories, Richland, Washington, July 3, 1974 [Discusses the Dog Inhalation Laboratory]
- CTRMN043224-3225 Council Manipulated Media on Smoking's Dangers [Discusses A Report Released by the House Energy and Commerce Health Subcommittee]
- CTRMN043226-3248 the Broadcast Reporting Service Tellex Report A Dying Industry [Discusses the Tobacco Industry As A Lobby]
- CTRMN043249-3258 State of Minnesota County of Ramsey District Court Second Judicial District Case Type: Other Civil Court File No. C1-94-8565 the State of Minnesota, by Humbert H. Humphrey, III, Its Attorney General, and Blue Cross Blue Shield of Minnesota, Plaintiffs, Vs. Philip Morris Incorporated, R.J. Reynolds Tobacco Corporation, B.A.T. Industries P.L.C., Lorillard Tobacco Company, the American Tobacco Company, Liggett Group, Inc., the Council for Tobacco Research -- U.S.A., Inc., and the Tobacco Institute, Inc., Defendants. Response of the Council for Tobacco Research -- U.S.A., Inc. To Plaintiffs' First Set for Requests for Admission [States Ctr's Position on A Number of Questions Regarding Cigarette Smoking As A Cause of Disease]
- CTRMN043259-3260 [Discussion of An Inhalation Project]
- CTRMN043261-3262 Report on Visit to U.S.A. And Canada 17th April - 12th May 1958 Attitude of U.S. Industry to Biological Testing [States That Liggett&Myers Stayed Out of TIRC Because They Doubted the Sincerity of TIRC Motives]
- CTRMN043263-3264 Auerbach's Smoking Beagles [Discusses Response of A Dog to An Inhalation Experiment States That These Methods Produced A Carcinoma in the Animal]
- CTRMN043265-3267 Review of Ctr Abstracts Dated 11/1/70 [Raises Questions About the Relevance of Ctr Grants to the Problem of Smoking and Health]
- CTRMN043268-3270 Auerbach/Hammond Paper [Gives Information on Auerbach's Inhalation Experiments Author Accepts That Significant Tumorogenic Conditions Following Inhalation Have Been Demonstrated]
- CTRMN043271-3274 Supplementary Report on Discussion with Osdene (Philip Morris) [Discussion of Long-Term Mouse Skin Painting]
- CTRMN043275-3276 Statement of F.G. Book in Buffalo, N.Y. On October 12, 1956 [Discusses Laboratory Research on the Subject of Tobacco]
- CTRMN043277-3279 Minutes of Meeting to Discuss Results of Experiments with Smoking Digs Conducted by Dr. Oscar Auerbach - Office of the Council for Tobacco Research, November 3, 1970 [St]
- CTRMN043280-3282 [Accepts Manuscript on Inhalation Studies for Publication]
- CTRMN043283-3285 [Discusses Who Will Serve on the Committee to Study Research Programs Funded by the Tobacco Industry]
- Author
- Gardner, W.U., Ctr
- Much, P.J., Houlihan Lokey Howard And Zukin
- Sommers, S.C., Lenox Hill Hospital
- Much, P.J., Houlihan Lokey Howard And Zukin
- Copied
- Teaman, A.
- Depository Date
- 08 Sep 1997
- Box
- 267
- Type
- LETTER
- UCSF Legacy ID
- ypt30a00
Document Images
ADVERTISING, R&D AND
YOUTH PREVENTION
(S Actual)
Philip Morris
Rnnrc! b Developmeel E:pnditrre.
(a) $32,169,534 5181,909,840 5590,534,587 S338,619,400 S1,IQ,23J,J61
Ceaa.a' . ln CTR
Coobbutioes to General Fund (b) $605,377 $2,007.624 $12.657,334 f41,J91,198 $50,682,505 5109,344,059
Contributions oo Special Projects (b) f0 98.000 1,041,004 4,523,946 174,973 5,837.923
To1sl Coartbaloea to CTR 5605,377 f2,105,624 _
f1J,698,J58 f47,915,144 _~-550857,478 SI15,181981
ResnrcM & Devebpneel Espt.dhern and
Co.eribetlou to CTR _
f605,377
$34.275.158
5195,WJ8,198
1618,449,7J1
$3119.476.1178
$1,_'58,415,342
AdverlYinB, M.rltel(e8 & Promolbe Espenditern
(c) -- 549,525,967 $1.231.550.409 56,965,180,581 110,144,056,314 $19.390.313.271
YoetA Pmentlne F-nredNnres
'
-
--
-
S 14
000
000
$14
000
000
Youth Prevention Eapeodihues (d)
You>r Prevenaoe Eapeodioun duouYh TI (e) _-
0
0
0
2,097,060 ,
,
4,721,680 .
,
6,818,740_
Total Ywtb Pme.tbe Espeedit.ro $2,097,060 f 1 S,721,680 S20 818~740
R.J. Revnolds
Rese.rnY & Devebpmenl Eapeodltrrn (Q 515,000,000 $558.387.000 $554,099,000 $1.127.496.000
Cnetih.ties. en CIR
Coe6butions to Geeersl Fund
(b) 51,792,006 $5.959.632 $17,683.774 $39.390,437 $34,858,068 $99,613,917
Contnbutions to Special Projects (b) 0 271,000 1,428,962 4.203.210 126,083 6,029,255
Total Coelr(brtioes to CTR S1 792 006 f6 230 6J2 $19,112,736 $4J 59J 647 S34,994,151 $105,713,172
RtsearN & Devebpme.t Espendlleres and
Cwtr(botb.e to CTR
$1,792,006
S6,2J0,632
$34.112.736
$601,980,647
5589,083,151
S1,?1J,199,172
AdveAW.B, Marknle8 Ar Proowtbn EspendRern
u Stated 1e Aeswer to Ielerroplory Na. 21. (j)
5234,044,522
5679,18J,762
$1,360.207.765
f5,165,99q679
52,293,864,000
SV,73,t,29o,728
} Y
~
E.d.ated AdverWinl, M.rketie8 & Pronwebn
[apsdk.w Reponad to FTC (b)
5234,044,522
$679.183.762
S1,S82,556,614
58,533,951,536
S8,140,288,160
519,170,024,594
/ Y Ynatr treveerte. i'.e.aeu..r.
YouA Preveeliow Eapmdimren (i)
Yowh Preveneoe Expnditura through T1(e)
0
0
0
1,896,194 514,000,000
3,203,423_ $14,000,000
5,099,617
+w T.W Y..tb Pmealon Eapeaditeres $1,896,194 117,203,423 $I9,099617
.~
.ri/l
01/02/97
CONF'IUGNTIAL - SU W LCT TO MINNESO'I'A PRO'fICCTIV E ORDL'R AND ADDENDUM \ CAItiGORY I

7)
ADVERTISING, R&D AND
YOUTH PREVENTION
(S Actual)
Philip Morris
Research & Development Expenditures (a) $1,143,233,361
Contibutions to CTR
Contibutions to General Fund (b) $109,344,059
Contributions to Special Projects (b) 5,837,923
Total Contributions to CTR $115,181,981
Research & Development Expenditures and
Contributions to CTR
$1,258,415,342
Advertising, Marketing & Promotion Expenditures (c) $18,390,313,271
Youth PreventionyXRej3Aitures
Youth Prevention Expenditures (d)
$14,000,000
Youth Prevention Expenditures through TI (e) 6,818,740
Total Youth Prevention Expenditures $20,818,740
Total Domestic Tobacco Sales (1954-1994) $141,442,700,000
Expenditure Comparison fvl
Advertising, Marketing & Promotion Expenditures to Total Domestic Tobacco Sales (1969-1994)
13.6%
Research & Development Expenditures to Total Domestic Tobacco Sales (1962-1994) 0.8%
Research & Development Expenditures and Contributions to CTR to Total Domestic Tobacco Sales
(1962-1994) 0.9%
Youth Prevention Expenditures to Total Domestic Tobacco Sales (1983-1994) 0.020%
Youth Prevention Expenditures to Total Domestic Tobacco Sales (1954-1994) 0.015%
Research & Development Expenditures to Advertising, Marketing & Promotion Expenditures
(1969-1994) 6.1%
Research & Development Expenditures and Contributions to CTR to Advertising, Marketing & Promotion
Exp. (1969-1994) 6.7%
Youth Prevention Expenditures to Advertising, Marketing & Promotion Expenditures (1983-19')4) 0.1%
Youth Prevention Expenditures to Advertising, Marketing & Promotion Expenditures (1969-1994) 0.1%
07/02/97 CONFIDENTIAL - SUBJECT TO MINNESOTA PROTECTIVE ORDER AND ADDENDUM \ CATEGORY I

ADVERTISING, R&D AND
YOUTH PREVENTION
(S Actual)
R.J. Reynolds
Research & Development Expenditures (Q 51,127,486,000
Contibottnw, to CTR
Cootibutions to General Fund (b) $99,683,917
Contributions to Special Projects (b) _ 6,029,255
Total Contributions to CTR S105713 ,,172
Research & Development Expenditures and
Contributions to CTR , S 1,233,199,172
Advertising, Marketing & Promotion Expenditures
as Stated In Answer to Interrogatory No. 21. (g) 59,733,296,728
Estimated Advertising, Marketing & Promotlo
Expenditures Reported to FTC (h) S 19,170,024,594
Yooth Preveotbo Pxnenditores
Youth Prevention Expenditures (i) 514,000,000
Youth Ptevention Expenditures through TI (c) 5,099,617
Total Youth Preve.tio. Expenditures S 19,099,617
Total Domestic Tobacco Sales (1954-1994) $118,621.736.975
Esocnditure Comparison /vl
Advertising, Marketing & Promotion Expenditures as Stated in Answer to Interrogatory No. 21 to
Total Domestic Tobacco Sales (1954-1994) 8.2%
Estimated Advertising. Marketing & Promotion Expenditures Reported to FTC to Total Domestic
Tobacco Salcs(1954-1994) 16.ri:
Research & Development Expenditures to Total Domestic Tobacco Sales (1964-1994) 1.1%
Research & Development Expenditures and Contnbutioos to CTR to Total Domestic Tobacco Sales
(1964-1994) 1.2%
Youth Prevention Expenditures to Total Domestic Tobacco Sales (1983-1994) 0.032%
Youth Prevention Expenditures to Total Domestic Tobacco Sales (1954-1994) 0.016/.
Research & Development Expenditures to Advertising, Marketing & Promotioo Expenditures as Stated in
Answer
w Intasrogatory No. 21 (1964-1994) 12.2%
Research & Development Expenditures to Estimated Advertising, Marketing & Promotion Expenditures
Reported
to FTC (1964-1994) 6.0%
Research & Development Expenditures and Contributions to CfR to Advertising. Marketing & Promotion
Expenditures u Stated in Answer to Interrogatory Nu. 21 (1 Wi4-19)4) 13.3%
Research & Development Expenditures and Contributions to CIR to Esunuted Advertising. Marketing &
Pronuxiun
Expenditura Reported to FTC (1964-1994) 6.6%
Youth Prevention Expenditures to Advertising Marketing & Promotion Expenditures as Stated in Answer
to
Interrogatroy No. 21 (1983-1994) 0.3%
Youth Prevention Expenditures lo Estimated Advertiaiag, Marketing & Promotion Expenditures Reported
to FiC (1983-1994) ' 0.1%
Youth Ptec vwtioa Expenditures to Advertising Marketing & Promotion Expenditures as Suted in Answer
to
Intertogatroy No. 21 (1954-1994) 0.2%
Youth Pteveotioo Expenditures to Estimated Advertising. Marketiog & Pmmotioo Expenditurcs Reported
to FTC (1954-1994) 0.1%
07/02/97 CONFIDENTIAL - SUBJECT TO MINNESOTA PROTECPIVE ORDER AND ADDENDUM \ CATEGORY I

CTR HN 043299

Philip Morris
Advertising, Marketing & Promotion to Total Domestic Tobacco Sales (1969-1994)
$18,390,313,271
~
-~..
.~..
E Total Domestic Tobacco Sales
m Advertising, Marketing & Promotion
07/02/97 CONFIDENTIAL - SUBJECT TO MINNESOTA PROTECTIVE ORDER AND ADDENDUM \ CATEGORY I

Philip Morris
Research & Development Expenditures to Total Domestic Tobacco Sales (1962-1994)
$138,612,700,000
~ Total Domestic Tobacco Sales
$1,143,233,361
Research & Development Expenditures
07/02/97 CONFIDENTIAL - SUBJECT TO MINNESOTA PROTECTIVE ORDER AND ADDENDUM \ CATEGORY I

Philip Morris
Research & Development Expenditures and Contributions to CTR to Total Domestic Tobacco Sales
(1962-1994)
$138,612,700,000
$1,257,607,747
. Total Domestic Tobacco Sales
m Research & Development Expenditures and Contributions to CTR
07/02/97 CONFIDENTIAL - SUBJECT TO MINNESOTA PROTECTIVE ORDER AND ADDENDUM \ CATEGORY I

Philip Morris
Youth Prevention Expenditures to Total Domestic Tobacco Sales (1983-199
$106,228,900,000
$20,818,740
m Domestic Tobacco Sales m Youth Prevention Expenditures
07/02/97 CONFIDENTIAL - SUBJECT TO MINNESOTA PROTECTIVE ORDER AND ADDENDUM \ CATEGORY I

f
--
Philip Morris
Youth Prevention Expenditures to Total Domestic Tobacco Sales (1954-1994)
$141,442,700,000
$20,818,740
0 Total Domestic Tobacco Sales w Youth Prevention Expenditures
07/02/97 CONFIDENTIAL - SUBJECT TO MINNESOTA PROTECTIVE ORDER AND ADDENDUM \ CATEGORY I

Philip Morris
Research & Development Expenditures to Advertising, Marketing & Promotion (1969-1994)
$1,117,050,580
m Advertising, Marketing & Promotion
. Research & Development Expenditures
07/02/97 CONFIDENTIAL - SUBJECT TO MINNESOTA PROTECTIVE ORDER AND ADDENDUM \ CATEGORY I
